Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Laetitia Da Meda"'
Autor:
Aline Rangel-Pozzo, Janine Wechsler, Jessica Groult, Laetitia Da Meda, Celeste Lebbe, Sabine Mai
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2391 (2022)
During phagocytosis, tumor-associated macrophages (TAMs) can incorporate genetic material from tumor cells. The incorporation of extra genetic material may be responsible for advanced malignant behavior observed in some TAMs, making TAMs potentially
Externí odkaz:
https://doaj.org/article/63dc12fd300c4fb8981e249cff3dcb5a
Autor:
Alison M. Weppler, Laetitia Da Meda, Ines Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Serigne N. Lo, Ina Nordman, Christopher B. Steer, Megan Lyle, Claudia Trojaniello, Paolo A. Ascierto, Celeste Lebbe, Shahneen Sandhu
Publikováno v:
European Journal of Cancer. 183:109-118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ccacc0bf02eeea3a83018e487fa1cc0
https://doi.org/10.1016/j.ejca.2023.01.016
https://doi.org/10.1016/j.ejca.2023.01.016
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Figure S2. (A) Change in the tumor burden from baseline over time according to RECIST for all the included patients. The tumor burden was measured as the sum of the longest diameters of target lesions. Each line represents a patient. (B) Kaplan-Meier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272e3c9431d2fe17ad4e23f5c0092460
https://doi.org/10.1158/1078-0432.22480554
https://doi.org/10.1158/1078-0432.22480554
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Purpose:In BRAFV600MUT metastatic melanoma, cyclin D–CDK4/6–INK4–Rb pathway alterations are involved in resistance to MAPK inhibitors, suggesting a clinical benefit of cyclin-dependent kinase 4 (CDK4) inhibitors. In this phase I–II study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3af0eef26415c8819e4c5b5543de08
https://doi.org/10.1158/1078-0432.c.6530460
https://doi.org/10.1158/1078-0432.c.6530460
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0cb79529fe16cf7b7f5ecfa443c579
https://doi.org/10.1158/1078-0432.22480545
https://doi.org/10.1158/1078-0432.22480545
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Tables S1, S2, S3, S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0565bed1a58abc520acba9f808af10fa
https://doi.org/10.1158/1078-0432.22480542
https://doi.org/10.1158/1078-0432.22480542
Autor:
Julie, Delyon, Lucie, Biard, Marion, Renaud, Matthieu, Resche-Rigon, Jérôme, Le Goff, Stéphane, Dalle, Valentine, Heidelberger, Laetitia, Da Meda, Laurie, Toullec, Guislaine, Carcelain, Samia, Mourah, Sophie, Caillat-Zucman, Vincent, Allain, Maxime, Battistella, Céleste, Lebbe
Publikováno v:
The Lancet Oncology. 23:491-500
Although the treatment of iatrogenic and HIV-related Kaposi sarcoma is well defined and mostly based on restoring immune function, the treatment of classic and endemic Kaposi sarcoma is less well established. Chemotherapy or interferon α is used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f1a2b92cd8c22943f8e31a947ea343
https://doi.org/10.1016/s1470-2045(22)00097-3
https://doi.org/10.1016/s1470-2045(22)00097-3
Autor:
Thierry Lesimple, Marc Pracht, Maxime Battistella, Matthieu Resche-Rigon, Caroline Dutriaux, Paul Vilquin, Annick Tibi, Zineb Ghrieb, Mona Amini-Adle, Barouyr Baroudjian, Coralie Reger de Moura, Samia Mourah, Samuel Huguet, Aurélie Sadoux, Baptiste Louveau, Didier Bouton, Céleste Lebbé, Julie Delyon, Fanélie Jouenne, Keyvan Rezai, Laetitia Da Meda
Publikováno v:
Clinical Cancer Research. 27:3876-3883
Purpose: In BRAFV600MUT metastatic melanoma, cyclin D–CDK4/6–INK4–Rb pathway alterations are involved in resistance to MAPK inhibitors, suggesting a clinical benefit of cyclin-dependent kinase 4 (CDK4) inhibitors. In this phase I–II study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d492ced8a91e50b08b33cdb4f9245222
https://doi.org/10.1158/1078-0432.ccr-20-4050
https://doi.org/10.1158/1078-0432.ccr-20-4050
Autor:
Aurélia Gruber, Céleste Lebbé, Julie Delyon, Fanélie Jouenne, Baptiste Louveau, Kevin Serror, Aminata Ndiaye, Aurélie Sadoux, Nicolas Dumaz, Pauline Tétu, Maxime Battistella, Laetitia Da Meda, O. Marco, Barouyr Baroudjian, Samia Mourah, Alban Lermine, Eddie Lopes
Publikováno v:
Targeted Oncology
Targeted Oncology, Springer Verlag (Germany), 2020, 15 (6), pp.759-771. ⟨10.1007/s11523-020-00764-4⟩
Targeted Oncology, Springer Verlag (Germany), 2020, 15 (6), pp.759-771. ⟨10.1007/s11523-020-00764-4⟩
International audience; Background: Tumor molecular deciphering is crucial in clinical management. Pan-cancer next-generation sequencing panels have moved towards exhaustive molecular characterization. However, because of treatment resistance and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97951d8babf3e68ebe276268805bffc
https://doi.org/10.1007/s11523-020-00764-4
https://doi.org/10.1007/s11523-020-00764-4
Autor:
Alexia Rivas, Julie Delyon, Antoine Martineau, Estelle Blanc, Clara Allayous, Laetitia Da Meda, Pascal Merlet, Céleste Lebbé, Barouyr Baroudjian, Laetitia Vercellino
Publikováno v:
Cancers
Cancers, 2022, 14 (13), pp.3190. ⟨10.3390/cancers14133190⟩
Cancers; Volume 14; Issue 13; Pages: 3190
Cancers, 2022, 14 (13), pp.3190. ⟨10.3390/cancers14133190⟩
Cancers; Volume 14; Issue 13; Pages: 3190
Background: Immune checkpoint inhibitors (ICI) are currently the first-line treatment for patients with metastatic melanoma. We investigated the value of positron emission tomography (PET) response criteria to assess the therapeutic response to first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16c5bcf59e89106418c97a49d1d8dad
https://www.hal.inserm.fr/inserm-03924569
https://www.hal.inserm.fr/inserm-03924569